Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Parathyroid Neoplasms 1Paraganglioma 1Multiple Endocrine Neoplasia 1Kidney Neoplasms 1Hypoglycemia 1Hyperparathyroidism 1Hypercalcemia 1Head and Neck Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

Parathyroidectomy 5Cinacalcet 3fluorocholine 2belinostat 2Trastuzumab 2Nivolumab 2Magnetic Resonance Spectroscopy 2Denosumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fluorodopa F 18 1evocalcet 1entinostat 1acetaminophen, codeine drug combination 1Tramadol 1Tablets 1Standard of Care 1Specimen Handling 1Sodium Chloride 1Rubidium-82 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parathyroid Neoplasms × gallium Ga 68 dotatate × Head & Neck × Clear all
NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
1,553 enrolled 8 charts
EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡